<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04444388</url>
  </required_header>
  <id_info>
    <org_study_id>UEM005</org_study_id>
    <nct_id>NCT04444388</nct_id>
  </id_info>
  <brief_title>Effect of Cocoa Supplementation in Training Athletes Microbiota and Metabolome</brief_title>
  <official_title>Effect of Cocoa Supplementation in Training Athletes Microbiota and Metabolome: Effects on Acute and Adaptive Exercise</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Europea de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Europea de Madrid</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has recently been suggested that cocoa may improve exercise performance and recovery. This&#xD;
      study aim to evaluate the plasma and fecal metabolome after 10 weeks of cocoa supplementation&#xD;
      during the training period in recreational athletes to detect possible metabolites involved&#xD;
      in the observed benefits of cocoa in athletes&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Actual">October 1, 2020</completion_date>
  <primary_completion_date type="Actual">October 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fecal microbiota</measure>
    <time_frame>Changes from baseline to 10 weeks of intervention</time_frame>
    <description>Abundance of bacterial taxa determined by 16SRNAr gene sequencing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fecal metabolome profile</measure>
    <time_frame>Changes from baseline to 10 weeks of intervention</time_frame>
    <description>Abundance of fecal metabolites, metabolic networks, and metabolic pathways determined by High Pressure Liquid Chromatography-Mass Spectrometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma metabolome profile</measure>
    <time_frame>Changes from baseline to 10 weeks of intervention</time_frame>
    <description>Abundance of blood metabolites, metabolic networks, and metabolic pathways activity determined by High Pressure Liquid Chromatography-Mass Spectrometry</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Healthy Athletes</condition>
  <arm_group>
    <arm_group_label>Cocoa group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 g/day of flavonoid-rich defatted cocoa for 10 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>5 g/day of maltodextrin for 10 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>cocoa</intervention_name>
    <description>Sachets of 5 grams of cocoa daily supplementation</description>
    <arm_group_label>Cocoa group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Sachets of 5 grams of maltodextrin daily supplementation</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-45 years of age&#xD;
&#xD;
          -  high physical condition (VO2 ≥ 55 ml/kg/min)&#xD;
&#xD;
          -  BMI 18-25 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  antibiotics intake during 3 months prior to the study,&#xD;
&#xD;
          -  smoking&#xD;
&#xD;
          -  nutritional complements&#xD;
&#xD;
          -  ergogenic complements&#xD;
&#xD;
          -  prebiotics&#xD;
&#xD;
          -  probiotics&#xD;
&#xD;
          -  vegetarian or vegan diet&#xD;
&#xD;
          -  chronic medication&#xD;
&#xD;
          -  gastrointestinal surgery&#xD;
&#xD;
          -  Any diagnosed disease&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mar Larrosa, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Europea de Madrid</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universidad Europea de Madrid</name>
      <address>
        <city>Villaviciosa de Odón</city>
        <state>Madrid</state>
        <zip>28670</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>June 18, 2020</study_first_submitted>
  <study_first_submitted_qc>June 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2020</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Europea de Madrid</investigator_affiliation>
    <investigator_full_name>Mar Larrosa</investigator_full_name>
    <investigator_title>Tenure Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

